284 related articles for article (PubMed ID: 34358560)
1. The SARS-CoV-2 Nsp3 macrodomain reverses PARP9/DTX3L-dependent ADP-ribosylation induced by interferon signaling.
Russo LC; Tomasin R; Matos IA; Manucci AC; Sowa ST; Dale K; Caldecott KW; Lehtiö L; Schechtman D; Meotti FC; Bruni-Cardoso A; Hoch NC
J Biol Chem; 2021 Sep; 297(3):101041. PubMed ID: 34358560
[TBL] [Abstract][Full Text] [Related]
2. Reconstitution of the DTX3L-PARP9 complex reveals determinants for high-affinity heterodimerization and multimeric assembly.
Ashok Y; Vela-Rodríguez C; Yang C; Alanen HI; Liu F; Paschal BM; Lehtiö L
Biochem J; 2022 Feb; 479(3):289-304. PubMed ID: 35037691
[TBL] [Abstract][Full Text] [Related]
3. Host ADP-ribosylation and the SARS-CoV-2 macrodomain.
Hoch NC
Biochem Soc Trans; 2021 Aug; 49(4):1711-1721. PubMed ID: 34351418
[TBL] [Abstract][Full Text] [Related]
4. PARP14 is regulated by the PARP9/DTX3L complex and promotes interferon γ-induced ADP-ribosylation.
Ribeiro VC; Russo LC; Hoch NC
EMBO J; 2024 Jun; ():. PubMed ID: 38834852
[TBL] [Abstract][Full Text] [Related]
5. Ubiquitin Modification by the E3 Ligase/ADP-Ribosyltransferase Dtx3L/Parp9.
Yang CS; Jividen K; Spencer A; Dworak N; Ni L; Oostdyk LT; Chatterjee M; Kuśmider B; Reon B; Parlak M; Gorbunova V; Abbas T; Jeffery E; Sherman NE; Paschal BM
Mol Cell; 2017 May; 66(4):503-516.e5. PubMed ID: 28525742
[TBL] [Abstract][Full Text] [Related]
6. PARP14 and PARP9/DTX3L regulate interferon-induced ADP-ribosylation.
Kar P; Chatrin C; Đukić N; Suyari O; Schuller M; Zhu K; Prokhorova E; Bigot N; Ahel J; Elsborg JD; Nielsen ML; Clausen T; Huet S; Niepel M; Sanyal S; Ahel D; Smith R; Ahel I
EMBO J; 2024 Jun; ():. PubMed ID: 38834853
[TBL] [Abstract][Full Text] [Related]
7. Synthetic Dual Cysteine-ADP Ribosylated Peptides from the Androgen Receptor are Recognized by the DTX3L/PARP9 Complex.
Wijngaarden S; Yang C; Vela-Rodríguez C; Lehtiö L; Overkleeft HS; Paschal BM; Filippov DV
ACS Chem Biol; 2023 Nov; 18(11):2377-2384. PubMed ID: 37939374
[TBL] [Abstract][Full Text] [Related]
8. The SARS-CoV-2 Conserved Macrodomain Is a Mono-ADP-Ribosylhydrolase.
Alhammad YMO; Kashipathy MM; Roy A; Gagné JP; McDonald P; Gao P; Nonfoux L; Battaile KP; Johnson DK; Holmstrom ED; Poirier GG; Lovell S; Fehr AR
J Virol; 2021 Jan; 95(3):. PubMed ID: 33158944
[TBL] [Abstract][Full Text] [Related]
9. The coronavirus macrodomain is required to prevent PARP-mediated inhibition of virus replication and enhancement of IFN expression.
Grunewald ME; Chen Y; Kuny C; Maejima T; Lease R; Ferraris D; Aikawa M; Sullivan CS; Perlman S; Fehr AR
PLoS Pathog; 2019 May; 15(5):e1007756. PubMed ID: 31095648
[TBL] [Abstract][Full Text] [Related]
10. KH-like Domains in PARP9/DTX3L and PARP14 Coordinate Protein-Protein Interactions to Promote Cancer Cell Survival.
Saleh H; Liloglou T; Rigden DJ; Parsons JL; Grundy GJ
J Mol Biol; 2024 Feb; 436(4):168434. PubMed ID: 38182103
[TBL] [Abstract][Full Text] [Related]
11. The Conserved Coronavirus Macrodomain Promotes Virulence and Suppresses the Innate Immune Response during Severe Acute Respiratory Syndrome Coronavirus Infection.
Fehr AR; Channappanavar R; Jankevicius G; Fett C; Zhao J; Athmer J; Meyerholz DK; Ahel I; Perlman S
mBio; 2016 Dec; 7(6):. PubMed ID: 27965448
[TBL] [Abstract][Full Text] [Related]
12. A Study into the ADP-Ribosylome of IFN-γ-Stimulated THP-1 Human Macrophage-like Cells Identifies ARTD8/PARP14 and ARTD9/PARP9 ADP-Ribosylation.
Higashi H; Maejima T; Lee LH; Yamazaki Y; Hottiger MO; Singh SA; Aikawa M
J Proteome Res; 2019 Apr; 18(4):1607-1622. PubMed ID: 30848916
[TBL] [Abstract][Full Text] [Related]
13. Macrodomain Mac1 of SARS-CoV-2 Nonstructural Protein 3 Hydrolyzes Diverse ADP-ribosylated Substrates.
Chea C; Lee DY; Kato J; Ishiwata-Endo H; Moss J
bioRxiv; 2023 Feb; ():. PubMed ID: 36945431
[TBL] [Abstract][Full Text] [Related]
14. ADP-ribosylhydrolases: from DNA damage repair to COVID-19.
Yu L; Liu X; Yu X
J Zhejiang Univ Sci B; 2021 Jan; 22(1):21-30. PubMed ID: 33448184
[TBL] [Abstract][Full Text] [Related]
15. Androgen signaling uses a writer and a reader of ADP-ribosylation to regulate protein complex assembly.
Yang CS; Jividen K; Kamata T; Dworak N; Oostdyk L; Remlein B; Pourfarjam Y; Kim IK; Du KP; Abbas T; Sherman NE; Wotton D; Paschal BM
Nat Commun; 2021 May; 12(1):2705. PubMed ID: 33976187
[TBL] [Abstract][Full Text] [Related]
16. PARP7 mono-ADP-ribosylates the agonist conformation of the androgen receptor in the nucleus.
Kamata T; Yang CS; Paschal BM
Biochem J; 2021 Aug; 478(15):2999-3014. PubMed ID: 34264286
[TBL] [Abstract][Full Text] [Related]
17. PARP14 is a PARP with both ADP-ribosyl transferase and hydrolase activities.
Đukić N; Strømland Ø; Elsborg JD; Munnur D; Zhu K; Schuller M; Chatrin C; Kar P; Duma L; Suyari O; Rack JGM; Baretić D; Crudgington DRK; Groslambert J; Fowler G; Wijngaarden S; Prokhorova E; Rehwinkel J; Schüler H; Filippov DV; Sanyal S; Ahel D; Nielsen ML; Smith R; Ahel I
Sci Adv; 2023 Sep; 9(37):eadi2687. PubMed ID: 37703374
[TBL] [Abstract][Full Text] [Related]
18. PARP14 is a writer, reader, and eraser of mono-ADP-ribosylation.
Torretta A; Chatzicharalampous C; Ebenwaldner C; Schüler H
J Biol Chem; 2023 Sep; 299(9):105096. PubMed ID: 37507011
[TBL] [Abstract][Full Text] [Related]
19.
Cantini F; Banci L; Altincekic N; Bains JK; Dhamotharan K; Fuks C; Fürtig B; Gande SL; Hargittay B; Hengesbach M; Hutchison MT; Korn SM; Kubatova N; Kutz F; Linhard V; Löhr F; Meiser N; Pyper DJ; Qureshi NS; Richter C; Saxena K; Schlundt A; Schwalbe H; Sreeramulu S; Tants JN; Wacker A; Weigand JE; Wöhnert J; Tsika AC; Fourkiotis NK; Spyroulias GA
Biomol NMR Assign; 2020 Oct; 14(2):339-346. PubMed ID: 32803496
[TBL] [Abstract][Full Text] [Related]
20. DTX3L and ARTD9 inhibit IRF1 expression and mediate in cooperation with ARTD8 survival and proliferation of metastatic prostate cancer cells.
Bachmann SB; Frommel SC; Camicia R; Winkler HC; Santoro R; Hassa PO
Mol Cancer; 2014 May; 13():125. PubMed ID: 24886089
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
